Search Results - "Arnqvist, HJ"

Refine Results
  1. 1

    The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods by Rawshani, Araz, Landin-Olsson, Mona, Svensson, Ann-Marie, Nyström, Lennarth, Arnqvist, Hans J., Bolinder, Jan, Gudbjörnsdottir, Soffia

    Published in Diabetologia (2014)
    “…Aims/hypothesis We reassessed the validity of previously reported incidence rates for type 1 diabetes in 0–34 year olds in Sweden. We estimated new incidence…”
    Get full text
    Journal Article
  2. 2

    Gestational diabetes: Glycaemic predictors for fetal macrosomia and maternal risk of future diabetes by Wahlberg, Jeanette, Ekman, Bertil, Nyström, Lennarth, Hanson, Ulf, Persson, Bengt, Arnqvist, Hans J

    Published in Diabetes research and clinical practice (01-04-2016)
    “…Highlights • Gestational diabetes was diagnosed with 75 g OGTT and 2 h capillary blood glucose ≥9 mmol/l. • Fasting blood glucose at diagnosis but not 2 h…”
    Get full text
    Journal Article
  3. 3

    Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion by Hedman, Christina A., Frystyk, Jan, Lindström, Torbjörn, Oskarsson, Per, Arnqvist, Hans J.

    Published in Clinical endocrinology (Oxford) (01-07-2014)
    “…Summary Objective Type 1 diabetes (T1D) is associated with low IGF‐I and altered levels of IGF‐binding proteins (IGFBPs) in plasma. This may be of importance…”
    Get full text
    Journal Article
  4. 4

    Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study by NORDWALL, M, BOJESTIG, M, ARNQVIST, H. J, LUDVIGSSON, J

    Published in Diabetologia (01-07-2004)
    “…In a previous study conducted over the last decades we found a decreased incidence of nephropathy but unchanged incidence of severe retinopathy among patients…”
    Get full text
    Journal Article
  5. 5
  6. 6

    C-Peptide Replacement Therapy and Sensory Nerve Function in Type 1 Diabetic Neuropathy by Ekberg, Karin, Brismar, Tom, Johansson, Bo-Lennart, Lindström, Per, Juntti-Berggren, Lisa, Norrby, Anders, Berne, Christian, Arnqvist, Hans J, Bolinder, Jan, Wahren, John

    Published in Diabetes care (2007)
    “…OBJECTIVE:--C-peptide replacement in animals results in amelioration of diabetes-induced functional and structural abnormalities in peripheral nerves. The…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells by Jamali, R, Bao, M, Arnqvist, HJ

    Published in Journal of endocrinology (01-11-2003)
    “…Apoptosis of vascular smooth muscle cells (VSMCs) is of importance in the development of diabetic angiopathy. Our aim was to evaluate the effect of insulin and…”
    Get full text
    Journal Article
  10. 10

    Impaired Absorption of Insulin Aspart From Lipohypertrophic Injection Sites by Johansson, Unn-Britt, Amsberg, Susanne, Hannerz, Lena, Wredling, Regina, Adamson, Ulf, Arnqvist, Hans J, Lins, Per-Eric

    Published in Diabetes care (01-08-2005)
    “…Johansson et al investigate whether the absorption of a single subcutaneous dose of insulin aspart is impaired when administered to lipohypertrophic tissue in…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells by Chisalita, Simona I, Arnqvist, Hans J

    “…Micro- and macroangiopathy are major causes of morbidity and mortality in patients with diabetes. Our aim was to characterize IGF-I receptor (IGF-IR) and…”
    Get more information
    Journal Article
  15. 15

    Assessment of beta‐cell function in young patients with type 2 diabetes: arginine‐stimulated insulin secretion may reflect beta‐cell reserve by Sjöstrand, M., Carlson, K., Arnqvist, H. J., Gudbjörnsdottir, S., Landin‐Olsson, M., Lindmark, S., Nyström, L., Svensson, M. K., Eriksson, J. W., Bolinder, J.

    Published in Journal of internal medicine (01-01-2014)
    “…Objective Simple methods for the evaluation of dynamic β‐cell function in epidemiological and clinical studies of patients with type 2 diabetes (T2D) are…”
    Get full text
    Journal Article
  16. 16

    Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells by Gustafsson, T, Andersson, P, Arnqvist, HJ

    Published in Journal of endocrinology (01-05-1999)
    “…IGF-I is involved in the regulation of metabolism, growth and migration of vascular smooth muscle cells (VSMCs). We have studied how IGFBP-1, -2 and -4…”
    Get full text
    Journal Article Conference Proceeding
  17. 17
  18. 18
  19. 19

    Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level by Johansson, G.S., Chisalita, S.I., Arnqvist, H.J.

    Published in Molecular and cellular endocrinology (16-12-2008)
    “…Human microvascular endothelial cells (HMVEC) are sensitive to IGF-I but insulin resistant and express several times more IGF-I receptors (IGF-IR) than insulin…”
    Get full text
    Journal Article
  20. 20

    Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis : a population-based study (DISS) in Sweden by WAERNBAUM, I, BLOHME, G, ÖSTMAN, J, SUNDKVIST, G, E RIKSSON, J. W, ARNQVIST, H. J, BOLINDER, J, NYSTRÖM, L

    Published in Diabetologia (01-04-2006)
    “…The objective of the study was to analyse the mortality, survival and cause of death patterns in incident cases of diabetes in the 15-34-year age group that…”
    Get full text
    Journal Article